Get the Stockscreener App
6.21
2.66%
-0.17
Alpha Cognition Inc stock is traded at $6.21, with a volume of 1,896.
It is down -2.66% in the last 24 hours and up +0.16% over the past month.
Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimers disease, for which there are limited or no treatment options. The Companies current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Companies commercial development program for ZUNVEYL is focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.
See More
Previous Close:
$6.38
Open:
$6.37
24h Volume:
1,896
Relative Volume:
0.03
Market Cap:
$138.92M
Revenue:
$10.22M
Net Income/Loss:
$-20.67M
P/E Ratio:
-5.2766
EPS:
-1.1769
Net Cash Flow:
$-20.72M
1W Performance:
+5.79%
1M Performance:
+0.16%
6M Performance:
+8.95%
1Y Performance:
-10.78%
1-Day Range:
$6.37
$6.38
1-Week Range:
$5.715
$6.50
52-Week Range:
$4.50
$11.54
Alpha Cognition Inc Stock (ACOG) Company Profile
Name
Alpha Cognition Inc
Sector
Industry
Phone
(858) 344-4375
Address
1452 HUGHES RD., STE. 200, GRAPEVINE
Compare ACOG vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ACOG
Alpha Cognition Inc
|
6.38 | 138.92M | 10.22M | -20.67M | -20.72M | -1.1769 |
VRTX
Vertex Pharmaceuticals Inc
|
428.69 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
721.51 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
808.49 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
305.51 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
309.49 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
Alpha Cognition Inc Stock (ACOG) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-17-26 | Initiated | Craig Hallum | Buy |
| Mar-18-25 | Initiated | H.C. Wainwright | Buy |
Alpha Cognition Inc Stock (ACOG) Latest News
Alpha Cognition Inc. Appoints Bethany Sensenig as Director and Files 8-K/A Amendment (NASDAQ: ACOG) - Minichart
When Will Alpha Cognition Inc. (NASDAQ:ACOG) Turn A Profit? - simplywall.st
Wall Street Zen Downgrades Alpha Cognition (NASDAQ:ACOG) to Sell - MarketBeat
Alpha Cognition (ACOG) adds Sensenig to key board committees and future Audit Chair role - Stock Titan
Alpha Cognition (NASDAQ: ACOG) maps 2026 AGM board slate and auditor - Stock Titan
Alpha Cognition Inc. (ACOG) reports Q4 loss, lags revenue estimates - MSN
Alpha Cognition Inc. (ACOG) soars 8.6%: Is further upside left in the stock? - MSN
Q1 EPS Estimates for Alpha Cognition Cut by HC Wainwright - MarketBeat
Alpha Cognition (Nasdaq: ACOG) to Report First Quarter 2026 Finan - The National Law Review
Alpha Cognition (Nasdaq: ACOG) to Report First Quarter 2026 Financial Results and Provide Business Update on Thursday, May 14, 2026 - The Joplin Globe
Alpha Cognition Inc. to Participate in Three Upcoming Investor ConferencesApril 27, 2026 - BioSpace
Alpha Cognition: Buy Rating Reaffirmed as Early Galantos Settlement Enhances Financial Flexibility; $18 Price Target Maintained - TipRanks
Alpha Cognition (NASDAQ:ACOG) Receives Buy Rating from HC Wainwright - MarketBeat
Short Interest in Alpha Cognition Inc. (NASDAQ:ACOG) Drops By 37.3% - MarketBeat
Alpha Cognition files $250M mixed securities shelf - MSN
Craig-Hallum initiates coverage of Alpha Cognition (ACOG) with buy recommendation - MSN
Alpha Cognition prices $35M public offering of common shares - MSN
Alpha Cognition appoints Bethany Sensenig to board of directors By Investing.com - Investing.com Australia
Alpha Cognition Strengthens Its Board of Directors with Appointment of Bethany Sensenig - BioSpace
Alpha Cognition appoints Bethany Sensenig to board of directors - Investing.com
Alpha Cognition Appoints Bethany Sensenig - TradingView
New Fortress Energy Inc. Announces Launch of Practice Statement Letter - Weekly Voice
Bethany Sensenig appointed to Alpha board as director - TradingView
Bethany Sensenig joins Alpha Cognition (NASDAQ: ACOG) board - Stock Titan
Is Alpha Cog (ACOG) stock stabilizing after decline (-0.79%) 2026-04-20Community Watchlist - Xã Thanh Hà
Alpha Cognition Inc.'s (NASDAQ:ACOG) Path To Profitability - Yahoo Finance
Alpha Cognition (NASDAQ:ACOG) Upgraded by Wall Street Zen to "Hold" Rating - MarketBeat
ACOG Initiated Coverage by Craig-Hallum -- Price Target Set at $14.00 - GuruFocus
Emmaus Life Sciences (EMMA) names Henry H. Du as new director - Stock Titan
Director at Alpha Cognition (ACOG) receives option and RSU grants - Stock Titan
[Form 3] Alpha Cognition Inc. Initial Statement of Beneficial Ownership - Stock Titan
Alpha Cognition (ACOG) Receives Buy Rating with $14 Price Target - GuruFocus
Craig-Hallum initiates Alpha Cognition stock with buy rating By Investing.com - Investing.com South Africa
Craig-Hallum initiates Alpha Cognition stock with buy rating - Investing.com
Craig-Hallum Initiates Alpha Cognition(ACOG.US) With Buy Rating, Announces Target Price $14 - Moomoo
Alpha Cognition Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Enidnews.com
Alpha Cognition Inc enters settlement agreement with Galantos Pharma on April 10, 2026SEC filing - marketscreener.com
Alpha Cognition IncEnters Settlement Agreement With Galantos Pharma On April 10, 2026SEC Filing - TradingView
[8-K] Alpha Cognition Inc. Reports Material Event - Stock Titan
Alpha Cognition Earnings Call: Early Traction, Rising Costs - TipRanks
Alpha Cognition Inc Stock (ACOG) Financials Data
Revenue
Net Income
Cash Flow
EPS
Alpha Cognition Inc Stock (ACOG) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Opaleye Management Inc. | 10% Owner |
Mar 30 '26 |
Buy |
4.99 |
1,850 |
9,227 |
2,471,850 |
| Opaleye Management Inc. | 10% Owner |
Mar 25 '26 |
Buy |
5.43 |
8,581 |
46,579 |
2,452,681 |
| Opaleye Management Inc. | 10% Owner |
Mar 26 '26 |
Buy |
5.28 |
7,319 |
38,675 |
2,460,000 |
| Opaleye Management Inc. | 10% Owner |
Mar 24 '26 |
Buy |
5.59 |
4,182 |
23,377 |
2,444,100 |
| Opaleye Management Inc. | 10% Owner |
Mar 18 '26 |
Buy |
5.75 |
2,481 |
14,263 |
2,437,824 |
| Opaleye Management Inc. | 10% Owner |
Mar 19 '26 |
Buy |
5.71 |
2,094 |
11,950 |
2,439,918 |
| Opaleye Management Inc. | 10% Owner |
Mar 16 '26 |
Buy |
5.78 |
1,331 |
7,696 |
2,435,343 |
| Opaleye Management Inc. | 10% Owner |
Mar 13 '26 |
Buy |
5.75 |
7,358 |
42,286 |
2,434,012 |
| Opaleye Management Inc. | 10% Owner |
Mar 12 '26 |
Buy |
5.85 |
5,708 |
33,416 |
2,426,654 |
| Opaleye Management Inc. | 10% Owner |
Mar 09 '26 |
Buy |
5.85 |
2,179 |
12,742 |
2,420,946 |
0.78%
3.01%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):